Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTOR | P42345 | 10/20 | 0.79 |
| ▸ | RPTOR | Q8N122 | 10/20 | 0.79 |
| ▸ | MLST8 | Q9BVC4 | 10/20 | 0.79 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | PARP1 | P09874 | 2/20 | 0.42 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.41 |
| ▸ | CFTR | P13569 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21360382 | 0.90 | MTOR (0.67) | MTORRPTORMLST8KDM4EALDH1A1 | |
| SCHEMBL22187978 | 0.90 | MTOR (0.69) | MTORRPTORMLST8KDM4EALDH1A1 | |
| SCHEMBL20150036 | 0.89 | MTOR (0.73) | MTORRPTORMLST8KDM4EALDH1A1 | |
| SCHEMBL20149839 | 0.88 | MTOR (0.65) | MTORRPTORMLST8KDM4EALDH1A1 | |
| SCHEMBL20149789 | 0.88 | MTOR (0.65) | MTORRPTORMLST8KDM4EALDH1A1 | |
| SCHEMBL22693183 | 0.88 | MTOR (0.67) | MTORRPTORMLST8KDM4EALDH1A1 | |
| SCHEMBL22693277 | 0.88 | MTOR (0.65) | MTORRPTORMLST8KDM4EALDH1A1 | |
| SCHEMBL20142627 | 0.88 | MTOR (1.00) | MTORRPTORMLST8KDM4EALDH1A1 | |
| SCHEMBL20133566 | 0.88 | MTOR (1.00) | MTORRPTORMLST8KDM4EALDH1A1 | |
| SCHEMBL20133746 | 0.88 | MTOR (1.00) | MTORRPTORMLST8KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200207716-A1 | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF | NAVITOR PHARMACEUTICALS, INC. | 2020-07-02 | — | — | US | disclosed |
| WO-2018089499-A1 | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF | NAVITOR PHARMACEUTICALS, INC. (US) | 2018-05-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200207716-A1 | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF | MTOR, RICTOR, RPTOR | MTOR 1/4885RPTOR 3/4885MLST8 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.